Valuation: Coral Laboratories Limited

Market Cap 1.97B 20.46M 18.16M 16.99M 15.4M 29.09M 29.3M 204M 79.39M 1.01B 76.79M 75.14M 3.23B P/E 2025
10.4x
P/E 2026 8.08x
Enterprise Value 1.71B 17.72M 15.73M 14.72M 13.34M 25.2M 25.38M 177M 68.77M 871M 66.52M 65.09M 2.8B EV / Sales 2025
1.94x
EV / Sales 2026 1.23x
Free-Float
19.97%
Yield 2025
0.21%
Yield 2026 0.54%
1 day-1.76%
1 week+1.05%
Current month-2.83%
1 month-3.83%
3 months-8.84%
6 months+40.48%
Current year+25.88%
1 week 510
Extreme 510
585
1 month 510
Extreme 510
604.8
Current year 360
Extreme 360
679
1 year 360
Extreme 360
679
3 years 262.05
Extreme 262.05
999
5 years 217
Extreme 217
999
10 years 81.2
Extreme 81.2
1,190
Manager TitleAgeSince
Director of Finance/CFO 49 2017-05-25
Director TitleAgeSince
Director/Board Member 45 2017-05-25
Director/Board Member 49 2017-05-25
Director/Board Member 40 2019-05-27
Change 5-day change 1-year change 3-year change Capi.($)
-1.76%+1.05%+5.90%+101.83% 20.84M
+1.33%-2.33%+36.91%+104.70% 1,019B
+0.79%-4.56%+35.72%+62.00% 610B
+0.45%+1.66%+16.27%+80.55% 470B
+1.29%-5.26%+59.26%+36.14% 344B
+0.26%+0.14%+21.29%+40.99% 336B
+0.60%-3.09%+10.76%+32.59% 266B
+1.65%-3.78%-6.03%+9.29% 241B
-0.19%-5.18%+36.58%+50.18% 218B
-0.41%-4.95%+26.60%+92.39% 179B
Average +0.39%-2.98%+24.33%+61.07% 368.29B
Weighted average by Cap. +0.82%-3.51%+29.52%+67.05%

Financials

2025 2026
Net sales 1.15B 11.93M 10.59M 9.91M 8.98M 16.96M 17.09M 119M 46.3M 587M 44.78M 43.82M 1.89B 859M 8.91M 7.91M 7.4M 6.71M 12.67M 12.76M 88.91M 34.58M 438M 33.45M 32.73M 1.41B
Net income 242M 2.51M 2.22M 2.08M 1.89M 3.56M 3.59M 25M 9.72M 123M 9.41M 9.2M 396M 164M 1.7M 1.51M 1.41M 1.28M 2.42M 2.43M 16.95M 6.59M 83.57M 6.38M 6.24M 269M
Net Debt -274M -2.84M -2.52M -2.36M -2.14M -4.04M -4.07M -28.35M -11.03M -140M -10.66M -10.44M -449M -264M -2.74M -2.43M -2.27M -2.06M -3.89M -3.92M -27.3M -10.62M -135M -10.27M -10.05M -433M
Projected Income Statement - Annual - Coral Laboratories Limited
Logo Coral Laboratories Limited
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.
Employees
149
Date Price Change Volume
26-10-06 ₹552.00 -1.76% 1,238
26-10-05 ₹561.90 +2.42% 599
26-10-01 ₹548.60 -3.42% 871
26-09-30 ₹568.05 +4.23% 1,435
26-09-29 ₹545.00 -0.23% 713
  1. Stock Market
  2. Stocks
  3. CORALAB6 Stock